A270 Sanitary Stainless Steel Tubing
For Dairy, Food, Beverage, and Other Sanitary Processes RathGibson's sanitary tubing exceeds ASTM A270 S2 and 3A specifications and most user specifications. It is manufactured from the finest quality stainless steel materials made
exclusively to the RathGibson melt criteria and formed by the RathGibson Micro-Weld process to assure weld seam integrity and industry leading ID and OD finishes to the low Ra values demanded by RathGibson's customers.
RathGibson leads the industry in manufacturing the highest quality welded sanitary tubing, backed with technical expertise, advanced manufacturing and polishing capabilities, and unmatched service before and after the sale. All standard sanitary tubing sizes are available in 1/2" (12.7 mm) to 8" (203.2 mm).
At Liquidyne, we prioritize our commitment to quality and consistency. In 2017 we achieved ISO 9001:2015 Quality Management System certification to ensure we can repeatedly deliver consistently high-quality products and solutions. Being an ISO 9001 facility, together with our USP Class VI Testing, ASME Bioprocessing Equipment (BPE), and EHEDG certification guarantee, we have the methodologies to assure quality. We will quickly and accurately rectify any issues if any of our products are ever in non-conformance.
"Thanks so much! What a quick turn around. It is a pleasure working with Liquidyne."
Process Development Manager
"I received the cart yesterday, thanks for the fast delivery! It feels sturdy. I sat on it. It does not bounce. It is also easy to clean and wipe or wash down."
Vice President, Analytical Development and Manufacturing
"Thanks again for reacting so quickly and meeting me halfway with the element. We will be able to get installed and have things keep moving overnight with the night crew. The little things like this are always greatly appreciated when working with Liquidyne."
“This pump cut our processing time from 3 days to 1 shift. I’m not giving this pump back. You will have to come and get it if you want it... and that won’t likely happen.”
VP Antibody Manufacturing